These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33411216)

  • 21. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
    Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
    Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
    Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I
    J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of methyl mercury exposure on pancreatic beta cell development and function.
    Schumacher L; Abbott LC
    J Appl Toxicol; 2017 Jan; 37(1):4-12. PubMed ID: 27594070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Unifying Hypothesis for Alzheimer's Disease: From Plaques to Neurodegeneration.
    Edwards FA
    Trends Neurosci; 2019 May; 42(5):310-322. PubMed ID: 31006494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
    Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.
    Saman S; Lee NC; Inoyo I; Jin J; Li Z; Doyle T; McKee AC; Hall GF
    J Alzheimers Dis; 2014; 40 Suppl 1(Suppl 1):S47-70. PubMed ID: 24718102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental and human exposure assessment monitoring of communities near an abandoned mercury mine in the Philippines: a toxic legacy.
    Maramba NP; Reyes JP; Francisco-Rivera AT; Panganiban LC; Dioquino C; Dando N; Timbang R; Akagi H; Castillo MT; Quitoriano C; Afuang M; Matsuyama A; Eguchi T; Fuchigami Y
    J Environ Manage; 2006 Oct; 81(2):135-45. PubMed ID: 16949727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological Signatures of Alzheimer's Disease.
    Sharma P; Sharma A; Fayaz F; Wakode S; Pottoo FH
    Curr Top Med Chem; 2020; 20(9):770-781. PubMed ID: 32108008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The toxicology of mercury.
    Clarkson TW
    Crit Rev Clin Lab Sci; 1997; 34(4):369-403. PubMed ID: 9288445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE].
    Szarka A
    Ideggyogy Sz; 2015 Jul; 68(7-8):222-8. PubMed ID: 26380416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.
    Wilcock DM
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.
    Singh RK
    Curr Neuropharmacol; 2020; 18(9):868-882. PubMed ID: 31989900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Etiology and pathogenesis of Alzheimer dementia].
    Kratzsch T; Peters J; Frölich L
    Wien Med Wochenschr; 2002; 152(3-4):72-6. PubMed ID: 11925775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
    Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
    Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
    Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The aging of central nervous system in methylmercury intoxication in Niigata, Japan--quantitative investigation of neurofibrillary tangles and senile plaques].
    Oyanagi K; Ikuta F
    No To Shinkei; 1993 Mar; 45(3):241-4. PubMed ID: 8323818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease.
    Uddin MS; Al Mamun A; Rahman MA; Behl T; Perveen A; Hafeez A; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
    Curr Top Med Chem; 2020; 20(26):2380-2390. PubMed ID: 32479244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topographic study of Alzheimer's neurofibrillary changes: a personal perspective.
    Hirano A; Iida M
    J Alzheimers Dis; 2006; 9(3 Suppl):53-60. PubMed ID: 16914844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.